Humacyte, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.0 | $0.0 | — | — | — |
| Operating income | -$108.1 | -$114.4 | -$100.0 | -$84.6 | -$81.2 |
| Net income | -$40.8 | -$148.7 | -$110.8 | -$12.0 | -$26.5 |
| Balance Sheet | |||||
| Total debt | — | — | — | $30.0 | — |
| Cash Flow Statement | |||||
| Free cash flow | -$105.9 | -$99.7 | -$75.6 | -$72.2 | -$81.4 |
| Dividends | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Shares outstanding 277.8M · Free float 84.4%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.